0001209191-16-146758.txt : 20161024
0001209191-16-146758.hdr.sgml : 20161024
20161024164453
ACCESSION NUMBER: 0001209191-16-146758
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161020
FILED AS OF DATE: 20161024
DATE AS OF CHANGE: 20161024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SWAIN PAULA J
CENTRAL INDEX KEY: 0001236934
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 161948489
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION
STREET 2: 3160 PORTER DRIVE
CITY: PALO LATO
STATE: CA
ZIP: 94304
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-10-20
0
0000879169
INCYTE CORP
INCY
0001236934
SWAIN PAULA J
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP, Human Resources
Common Stock
2016-10-20
4
M
0
10000
14.72
A
39248
D
Common Stock
2016-10-20
4
S
0
10000
90.00
D
29248
D
Non-Qualified Stock Option (right to buy)
14.72
2016-10-20
4
M
0
10000
0.00
D
2018-01-24
Common Stock
10000
2317
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Includes an aggregate of 11,187 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Beginning January 25, 2011, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
/s/ Paula Swain
2016-10-24